tiprankstipranks
Edwards Lifesciences (EW)
NYSE:EW
US Market

Edwards Lifesciences (EW) Financial Statements

Compare
1,854 Followers

Edwards Lifesciences Financial Overview

Edwards Lifesciences's market cap is currently $44.63B. The company's EPS TTM is $6.972; its P/E ratio is 10.71; Edwards Lifesciences is scheduled to report earnings on January 30, 2025, and the estimated EPS forecast is $0.60. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 6.00B$ 5.38B$ 5.23B$ 4.39B$ 4.35B
Gross Profit$ 4.63B$ 4.30B$ 3.98B$ 3.31B$ 3.23B
Operating Income$ 1.53B$ 1.75B$ 1.35B$ 1.63B$ 1.15B
EBITDA$ 1.77B$ 1.96B$ 1.89B$ 1.07B$ 1.31B
Net Income$ 1.40B$ 1.52B$ 1.50B$ 823.40M$ 1.05B
Balance Sheet
Cash & Short-Term Investments$ 1.64B$ 1.22B$ 1.47B$ 1.40B$ 1.52B
Total Assets$ 9.36B$ 8.29B$ 8.50B$ 7.24B$ 6.49B
Total Debt$ 694.90M$ 691.30M$ 690.30M$ 694.90M$ 678.80M
Net Debt$ -449.10M$ -77.70M$ -172.50M$ -488.30M$ -500.30M
Total Liabilities$ 2.64B$ 2.49B$ 2.67B$ 2.66B$ 2.34B
Stockholders' Equity$ 6.65B$ 5.81B$ 5.84B$ 4.57B$ 4.15B
Cash Flow
Free Cash Flow$ 629.50M$ 953.40M$ 1.40B$ 647.00M$ 901.00M
Operating Cash Flow$ 895.80M$ 1.22B$ 1.73B$ 1.05B$ 1.18B
Investing Cash Flow$ 173.80M$ 252.30M$ -1.72B$ -531.10M$ -595.80M
Financing Cash Flow$ -711.00M$ -1.58B$ -356.30M$ -486.90M$ -115.60M
Currency in USD

Edwards Lifesciences Earnings and Revenue History

Edwards Lifesciences Debt to Assets

Edwards Lifesciences Cash Flow

Edwards Lifesciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis